TY - JOUR
T1 - HIGH-RISK HISTOPATHOLOGICAL FEATURES OF RETINOBLASTOMA FOLLOWING PRIMARY ENUCLEATION
T2 - A Global Study Of 1,426 Patients From 5 Continents
AU - Highrisk Retinoblastoma Collaborative Study Group
AU - Kaliki, Swathi
AU - Vempuluru, Vijitha S.
AU - Bakal, Komal Rajendra
AU - Dorji, Samten
AU - Tanna, Vishakha
AU - Shields, Charlotte N.
AU - Fallon, Samuel J.
AU - Raval, Vishal
AU - Ahmad, Alia
AU - Mushtaq, Asma
AU - Hussain, Mahvish
AU - Yousef, Yacoub A.
AU - Mohammad, Mona
AU - Roy, Soma Rani
AU - Huque, Fahmida
AU - Tatiana, Ushakova
AU - Yuri, Serov
AU - Vladimir, Polyakov
AU - Zambrano, Sandro Casavilca
AU - Alarcón-León, Sandra
AU - Valdiviezo-Zapata, Cinthya
AU - Vargas-Martorellet, Maria
AU - Gutierrez-Chira, Cynthia
AU - Buitrago, Mario
AU - Ortiz, Joana Sánchez
AU - Diaz-Coronado, Rosdali
AU - Tripathy, Devjyoti
AU - Rath, Suryasnata
AU - Patil, Gaurav
AU - Berry, Jesse L.
AU - Pike, Sarah
AU - Brown, Brianne
AU - Tanabe, Mika
AU - Frenkel, Shahar
AU - Eiger-Moscovich, Maya
AU - Pe'er, Jacob
AU - Shields, Carol L.
AU - Eagle, Ralph C.
AU - Laiton, Andrea
AU - Velasco, Ana Maria
AU - Vega, Katherine
AU - Desimone, Joseph
AU - Bejjanki, Kavya Madhuri
AU - Kapoor, Anasua Ganguly
AU - Venkataraman, Anusha
AU - Bryant, Victoria
AU - Reddy, M. Ashwin
AU - Sagoo, Mandeep S.
AU - Hubbard, G. Baker
AU - Azarcon, Corrina P.
N1 - Publisher Copyright:
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.
PY - 2024/12/1
Y1 - 2024/12/1
N2 - Purpose: To evaluate high-risk histopathological features following primary enucleation of eyes with retinoblastoma and assess the patient outcomes across continents. Methods: A retrospective study of 1,426 primarily enucleated retinoblastoma eyes from five continents. Results: Of all, 923 (65%) were from Asia (AS), 27 (2%) from Australia (AUS), 120 (8%) from Europe (EUR), 162 (11%) from North America (NA), and 194 (14%) from South America (SA). Based on the continent (AS vs. AUS vs. EUR vs. NA vs. SA), the histopathological features included massive choroidal invasion (31% vs. 7% vs. 13% vs. 19% vs. 27%, P = 0.001), postlaminar optic nerve invasion (27% vs. 0% vs. 16% vs. 21% vs. 19%, P = 0.0006), scleral infiltration (5% vs. 0% vs. 4% vs. 2% vs. 7%, P = 0.13), and microscopic extrascleral infiltration (4% vs. 0% vs. <1% vs. <1% vs. 4%, P = 0.68). Adjuvant chemotherapy with/without orbital radiotherapy was given to 761 (53%) patients. Based on Kaplan-Meier estimates in different continents (AS vs. AUS vs. EUR vs. NA vs. SA), the 6-year risk of orbital tumor recurrence was 5% versus 2% versus 0% versus 0% versus 12% (P < 0.001), systemic metastasis was reported in 8% versus 5% versus 2% versus 0% versus 13% (P = 0.001), and death in 10% versus 3% versus 2% versus 0% versus 11% (P < 0.001) patients. Conclusion: There is a wide variation in the infiltrative histopathological features of retinoblastoma across continents, resulting in variable outcomes. SA and AS had a higher risk of orbital tumor recurrence, systemic metastasis, and death compared to AUS, EUR, and NA.
AB - Purpose: To evaluate high-risk histopathological features following primary enucleation of eyes with retinoblastoma and assess the patient outcomes across continents. Methods: A retrospective study of 1,426 primarily enucleated retinoblastoma eyes from five continents. Results: Of all, 923 (65%) were from Asia (AS), 27 (2%) from Australia (AUS), 120 (8%) from Europe (EUR), 162 (11%) from North America (NA), and 194 (14%) from South America (SA). Based on the continent (AS vs. AUS vs. EUR vs. NA vs. SA), the histopathological features included massive choroidal invasion (31% vs. 7% vs. 13% vs. 19% vs. 27%, P = 0.001), postlaminar optic nerve invasion (27% vs. 0% vs. 16% vs. 21% vs. 19%, P = 0.0006), scleral infiltration (5% vs. 0% vs. 4% vs. 2% vs. 7%, P = 0.13), and microscopic extrascleral infiltration (4% vs. 0% vs. <1% vs. <1% vs. 4%, P = 0.68). Adjuvant chemotherapy with/without orbital radiotherapy was given to 761 (53%) patients. Based on Kaplan-Meier estimates in different continents (AS vs. AUS vs. EUR vs. NA vs. SA), the 6-year risk of orbital tumor recurrence was 5% versus 2% versus 0% versus 0% versus 12% (P < 0.001), systemic metastasis was reported in 8% versus 5% versus 2% versus 0% versus 13% (P = 0.001), and death in 10% versus 3% versus 2% versus 0% versus 11% (P < 0.001) patients. Conclusion: There is a wide variation in the infiltrative histopathological features of retinoblastoma across continents, resulting in variable outcomes. SA and AS had a higher risk of orbital tumor recurrence, systemic metastasis, and death compared to AUS, EUR, and NA.
KW - chemotherapy
KW - enucleation
KW - eye
KW - high-risk features
KW - histopathology
KW - retinoblastoma
KW - tumor
UR - http://www.scopus.com/inward/record.url?scp=85201768949&partnerID=8YFLogxK
U2 - 10.1097/IAE.0000000000004250
DO - 10.1097/IAE.0000000000004250
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 39151183
AN - SCOPUS:85201768949
SN - 0275-004X
VL - 44
SP - 2105
EP - 2115
JO - Retina
JF - Retina
IS - 12
ER -